>>Signaling Pathways>> Proteases>> Mitochondrial Metabolism>>Tempo

Tempo Sale

Catalog No.GC39512

Tempo는 전형적인 니트록사이드 라디칼이며 촉매 사이클에서 슈퍼옥사이드를 불연소화하는 ROS의 선택적 스캐빈저입니다. 템포는 DNA 가닥 파손을 유도합니다. Tempo는 1차 알코올을 알데히드로 산화시키는 유기 촉매로 사용할 수 있습니다. 템포는 돌연변이 유발 및 항산화 효과가 있습니다.

Products are for research use only. Not for human use. We do not sell to patients.

Tempo Chemical Structure

Cas No.: 2564-83-2

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$43.00
재고 있음
100mg
US$39.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Chemical Properties Product Documents Related Products

Tempo is a classic nitroxide radical and is a selective scavenger of mitochondrial ROS that dismutases superoxide in the catalytic cycle. Tempo induces DNA-strand breakage. Tempo can be used as an organocatalyst for the oxidation of primary alcohols to aldehydes. Tempo has mutagenic and antioxidant effects[1][2][3][4].

[1]. Du K, et al. Mitochondria-targeted antioxidant Mito-Tempo protects against acetaminophen hepatotoxicity. Arch Toxicol. 2017 Feb;91(2):761-773. [2]. Guo X, et al. Comparative Genotoxicity of TEMPO and 3 of Its Derivatives in Mouse Lymphoma Cells. Toxicol Sci. 2018 May 1;163(1):214-225. [3]. Lv H, et al. TEMPO catalyzed oxidative dehydrogenation of hydrazobenzenes to azobenzenes. Org Biomol Chem. 2020 Apr 22. [4]. Chen X, et al. Isocitrate dehydrogenase 2 contributes to radiation resistance of oesophageal squamous cell carcinoma via regulating mitochondrial function and ROS/pAKT signalling. Br J Cancer. 2020 May 5.

리뷰

Review for Tempo

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tempo

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.